TRASTUZUMAB BIOSIMILARS MARKET OUTLOOK FOR 2024

Trastuzumab, a monoclonal antibody used in treating HER2-positive breast cancer, has significantly improved cancer treatment by specifically targeting the HER2 receptor, which is overexpressed in certain breast cancer cases. As the demand for more affordable therapies grows, trastuzumab biosimilars have emerged as a key solution, providing greater